


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.61%
+2.74%
+0.46%
+0.52%
-3.04%
APLS
Apellis Pharmaceuticals I
$21.70
Strengths

Upgraded on attractively valued

Trading below its fair value
Technical Indicators

5+ Days Down
APLS Price Performance
$20.47 (+6.01%)
$19.45 (+11.57%)
$23.19 (-6.43%)
$25.05 (-13.37%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Trading below its fair value
![]()
APLS Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
APLS Street Sentiment is bullish and have positive views on the near-term outlook
APLS has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 30, 2026
Upgrade
Buy
BofA
Jan 21, 2026
Upgrade
Buy
B of A Securities
Nov 06, 2025
Reiterate
Overweight
JP Morgan
Nov 04, 2025
Reiterate
Neutral
Mizuho
Oct 31, 2025
Reiterate
Buy
HC Wainwright & Co.
What is APLS current stock price?
What are APLS stock strengths?
What is APLS Risk Level?
What is APLS market cap and volume?
What is APLS current Stock IQ?
Should I buy APLS stock right now?
Is APLS a Strong Buy right now?
What does a 'Strong Buy' rating mean for APLS?
What does a 'Strong Sell' rating mean for APLS?
What factors influence APLS's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.61%
+2.74%
+0.46%
+0.52%
-3.04%
APLS
Apellis Pharmaceuticals I
Current Price
$21.70

APLS Price Performance
$20.47 (+6.01%)
$19.45 (+11.57%)
$23.19 (-6.43%)
$25.05 (-13.37%)
APLS Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Trading below its fair value
![]()
APLS Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
APLS Street Sentiment is bullish and have positive views on the near-term outlook
APLS has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 30, 2026
Upgrade
Buy
BofA
Jan 21, 2026
Upgrade
Buy
B of A Securities
Nov 06, 2025
Reiterate
Overweight
JP Morgan
Nov 04, 2025
Reiterate
Neutral
Mizuho
Oct 31, 2025
Reiterate
Buy
HC Wainwright & Co.
APLS Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value
Technical Indicators

5+ Days Down
APLS Latest Analysis
BofA Upgrades Apellis (APLS) to Buy Citing Rapid Empaveli Adoption and Underappreciated Kidney Disease Market Potential. Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the best high short interest stocks with biggest upside potential. On January 21 Bank of America analyst Tazeen Ahmad upgraded Apellis to Buy from Neutral with an unchanged price target of $28. BofA maintains that the market is currently undervaluing Empavelis commercial prospects in treating rare kidney diseases [….]
Fri Jan 30, 2026
Barclays Initiates Coverage of Apellis Pharmaceuticals (APLS) with Equal-Weight Recommendation. Fintel reports that on January 28 2026 Barclays initiated coverage of Apellis Pharmaceuticals (NasdaqGS:APLS) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 56.04% Upside
Thu Jan 29, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
APLS Stock trends
APLS Stock performance
APLS Stock analysis
APLS investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.